Ignite Creation Date:
2024-10-25 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06568159
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-26
Brief Title:
Patients With Coronary Artery Disease or at High Cardiovascular Risk Measuring Compliance With Treatment for Obstructive Sleep Apnea Syndrome
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Patients With Coronary Artery Disease or at High Cardiovascular Risk Measuring Compliance With Treatment for Obstructive Sleep Apnea Syndrome OAM or CPAP
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PACOAM
Brief Summary:
Obstructive sleep apnea OSA is a sleep disorder characterised by partial or total obstruction of the oro-pharyngeal carrefour during sleep It is found in between 4 and 25 of the general population and in 40 to 80 of patients with cardiovascular diseases
Continuous positive airway pressure CPAP is the standard treatment for OSA and its efficacy has already been demonstrated in this particular population However this treatment is not always accepted or sufficiently tolerated The mandibular advancement device MAD is therefore an alternative treatment for OSA validated by the French National Authority for Health and particularly relevant in this population because it is generally better tolerated The aim of our study was to assess compliance tolerance and usability of CPAP and MAD in patients with coronary artery disease and moderate Apnea-Hypopnea Index AHI 15-30 to severe AHI30 OSA
Continuous positive airway pressure CPAP is the standard treatment for OSA and its efficacy has already been demonstrated in this particular population However this treatment is not always accepted or sufficiently tolerated The mandibular advancement device MAD is therefore an alternative treatment for OSA validated by the French National Authority for Health and particularly relevant in this population because it is generally better tolerated The aim of our study was to assess compliance tolerance and usability of CPAP and MAD in patients with coronary artery disease and moderate Apnea-Hypopnea Index AHI 15-30 to severe AHI30 OSA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None